By taking advantage of the long-read and single molecular sequencing capability developed by PacBio, we are proud to offer advanced genome de novo assembly solutions and full-length gene/transcript sequencing strategy to suit your project needs.
Single-cell sequencing represents a significant advancement in our comprehension of cellular heterogeneity and biological processes. This sophisticated technology facilitates the examination of genomes, transcriptomes, epigenomes, and proteomes at the single-cell resolution, thereby delivering unparalleled insights into cellular functions and interactions. In contrast to conventional bulk sequencing, which yields averaged data from a mixture of cells, single-cell sequencing discloses the distinct molecular signatures of individual cells, thereby unveiling the intricate complexity and diversity present within tissues and organisms.
Taking the transcriptome as an example, traditional bulk RNA sequencing (Bulk RNA-seq) involves extracting and sequencing the mixed RNA from tissues, organs, or clusters of cells, yielding average transcriptomic data for those cell populations. For instance, using Bulk RNA-seq, one can identify differential gene expression between tumor and adjacent non-tumor tissues, noting variations in oncogenes and tumor suppressor genes. However, within a tumor, there exist genetic and transcriptomic variations among cells located at the tumor core, periphery, lymphatic metastases, and distant metastases. These differences may play critical roles in cancer cell invasion, metastasis, and the evolution of drug resistance, subsequently influencing the efficacy of therapeutic interventions.
Conversely, single-cell RNA sequencing (scRNA-seq) allows for the examination of tumor heterogeneity at the individual cell level. This technique facilitates the study of clonal evolution and development of cancer cells, early-stage cancer invasion, mutation rates and types in cancer cells, tracking of metastasis and dissemination, characterization of the tumor microenvironment, and understanding the evolution of drug resistance during cancer treatment.
Early approaches to single-cell sequencing involved isolating individual cells followed by low-input library preparation and sequencing. Methods for isolating single cells encompassed techniques such as limiting dilution, flow cytometry, laser capture microdissection, and micromanipulation. While these methods are capable of isolating single cells, they are often complex, time-consuming, costly, and low in throughput, which hinders their widespread application on a large scale.